STOA Working Breakfast - Solving Antimicrobial Resistance
During the STOA Working Breakfast co-organised by the European Parliament´s STOA, EuCheMS, and EFMC on the 28 April 2016, researchers and several Members of the European Parliament analysed the global challenge of antimicrobial resistance and weighted the pros and cons of possible solutions.
Antimicrobial Resistance (AMR) is the ability of microorganisms to withstand attack by antimicrobial drugs such as antibiotics, antifungal or antivirals, and is a serious issue that threatens to render many of the treatments we use today ineffective in the future – from tuberculosis to HIV, from pneumonia to other common infections.
The STOA Working Breakfast was an outcome of the work of the EFMC Working group on “Influence on European science policy”, chaired by Anders Karlén, in collaboration with EuCheMS.
(please note that the outcomes will also soon be available at STOA´s website)
Workshop Outcomes – Forward Look
This workshop attracted a capacity audience including at least six MEPs. It was chaired by Paul Rübig MEP, Chair of STOA.
Clear recommendations emerged from the Workshop. These include:
Solving antibiotic resistance: an introduction – David Cole-Hamilton, EuCheMS President
Making choices on antibiotics (presentation to be uploaded soon) – Chris Schofield, University of Oxford
What it there are no new antibiotics? – Lloyd Czaplewski, Chemical Biology Ventures Ltd
Antibiotic resistance: strategy and activities of the Institut Pasteur – Philippe Glaser, Institut Pasteur
EFMC Awards 2016
The EFMC is pleased to announce the recipients of the 2016 Awards:
The Awards will be presented during the XXIV International Symposium on Medicinal Chemistry (EFMC-ISMC 2016), scheduled to be held on August 28 – September 1, 2016 in Manchester, United Kingdom.
EFMC Prizes 2016
The Selection Committees are proud to announce the names of the winner and the most meritorious runners-up of the EFMC Prize for a Young Medicinal Chemist in Industry and the EFMC Prize for a Young Medicinal Chemist in Academia.
EFMC PRIZE FOR A YOUNG MEDICINAL CHEMIST IN INDUSTRY
Jean Quancard (Novartis Pharma, Switzerland)
EFMC PRIZE FOR A YOUNG MEDICINAL CHEMIST IN ACADEMIA
Frank Boeckler (Eberhard Karls University Tuebingen, Germany)
The EFMC Prizes Ceremony will take place during the XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) in Manchester, UK, on August 28-September 1, 2016. Dr Jean Quancard and Prof. Frank Boeckler will be invited to give an Oral Communication during the Symposium.
XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016)
August 28 - September 1, 2016 - Manchester, United Kingdom
The XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) will be organised by the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry, on behalf of the European Federation for Medicinal Chemistry (EFMC).
For more information please visit EFMC-ISMC 2016
Organised by : European Federation for Medicinal Chemistry (EFMC)
Organised by : The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)
3rd EFMC Young Medicinal Chemist Symposium (EFMC-YMCS)
The EFMC Young Medicinal Chemist Symposium is an initiative of the European Federation for Medicinal Chemistry (EFMC). After a succesful first edition organised in Lisbon in September 2014 and a second edition organised in Antwerp in September 2015, the third edition will be organised in connection with XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016), and will take place in Manchester (United Kingdom) on September 1-2, 2016.
This short symposium has the aim of:
For more information please visit www.efmc-ymcs.org
What are your colleagues reading in MedChemComm? Find out more here: Most read articles !